ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

ALIM Company Profile and Key Details

NASDAQ : ALIM

Alimera Sciences, Inc.

$5.54

-0.01-0.18%

At Close 4:00 PM

Not Actively Trading

62.83

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

ALIM Stock Price Chart

Stock Price Today

Alimera Sciences, Inc. (ALIM) stock declined over -0.18%, trading at $5.54 on NASDAQ, down from the previous close of $5.55. The stock opened at $5.55, fluctuating between $5.53 and $5.56 in the recent session.

Stock Snapshot

5.55

Prev. Close

5.55

Open

301.29M

Market Cap

54.38M

Number of Shares

5.53

Day Low

5.56

Day High

5.276190476190476

P/E Ratio

24.23%

Free Float in %

1.05

EPS (TTM)

0.85

Book Value

-1.65

Cash Flow per Share

2.68M

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 18, 2024	5.54	5.54	5.54	5.54	0
Sep 17, 2024	5.54	5.54	5.54	5.54	0
Sep 16, 2024	5.54	5.54	5.54	5.54	0
Sep 13, 2024	5.55	5.56	5.53	5.54	2.68M
Sep 12, 2024	5.54	5.57	5.54	5.55	705.9K
Sep 11, 2024	5.53	5.56	5.52	5.53	2.11M
Sep 10, 2024	4.66	5.29	4.32	5.19	8.68M
Sep 09, 2024	5.56	5.57	5.53	5.55	1.59M
Sep 06, 2024	5.55	5.63	5.54	5.56	9.09M
Sep 05, 2024	5.56	5.56	5.53	5.54	1.19M
Sep 04, 2024	5.53	5.56	5.52	5.54	1.65M
Sep 03, 2024	5.55	5.56	5.51	5.52	1.03M
Aug 30, 2024	5.56	5.57	5.53	5.53	1.1M
Aug 29, 2024	5.57	5.58	5.53	5.54	2.26M
Aug 28, 2024	5.59	5.59	5.55	5.55	751.33K
Aug 27, 2024	5.59	5.60	5.58	5.59	268.4K
Aug 26, 2024	5.60	5.60	5.59	5.60	165.13K
Aug 23, 2024	5.59	5.60	5.58	5.59	210.6K
Aug 22, 2024	5.59	5.60	5.58	5.58	95.9K
Aug 21, 2024	5.60	5.60	5.58	5.59	65.7K

Contact Details

Alpharetta, GA 30005

United States

Website: https://alimerasciences.comContact: 678 990 5740

About Company

Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals in the United States and internationally. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and lead to severe vision loss and blindness; and to prevent relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye. The company sells its products to physician offices, pharmacies, and hospitals through direct sales and distributors. It has a collaboration agreement with EyePoint Pharmaceuticals US, Inc. for the development and sale of insert technology to deliver other corticosteroids to the back of the eye for the treatment and prevention of eye diseases in humans or to treat diabetic macular edema. The company was incorporated in 2003 and is headquartered in Alpharetta, Georgia.

Frequently Asked Questions

What is the current Alimera Sciences, Inc. (ALIM) stock price?

Alimera Sciences, Inc. (NASDAQ: ALIM) stock price is $5.54 in the last trading session. During the trading session, ALIM stock reached the peak price of $5.56 while $5.53 was the lowest point it dropped to. The percentage change in ALIM stock occurred in the recent session was -0.18% while the dollar amount for the price change in ALIM stock was -$0.01.

ALIM's industry and sector of operation?

The NASDAQ listed ALIM is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector. Alimera Sciences, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of ALIM?

Mr. Charles Daniel Myers
Non-Executive Chairman & Consultant
Mr. John Philip Jones
Chief Financial Officer
Christopher S. Visick
Vice President, Gen. Counsel & Sec.
Mr. Richard S. Eiswirth Jr.
Pres, Chief Executive Officer & Director
Dr. Philip Ashman Ph.D.
Chief Operating Officer & Senior Vice President of Commercial Operations - Europe
Mr. Russell L. Skibsted M.B.A.
Senior Vice President & Chief Financial Officer
Mr. David R. Holland
Co-Founder, Chief Marketing Officer and Senior Vice President of Corporation Communications & Managed Markets
Dr. David Dyer M.D.
Chief Retina Specialist

How ALIM did perform over past 52-week?

ALIM's closing price is 112.59% higher than its 52-week low of $2.61 where as its distance from 52-week high of $5.65 is -1.95%.

How many employees does ALIM have?

Number of ALIM employees currently stands at 154.

Link for ALIM official website?

Official Website of ALIM is: https://alimerasciences.com

How do I contact ALIM?

ALIM could be contacted at phone 678 990 5740 and can also be accessed through its website. ALIM operates from 6310 Town Square, Alpharetta, GA 30005, United States.

How many shares of ALIM are traded daily?

ALIM stock volume for the day was 2.68M shares. The average number of ALIM shares traded daily for last 3 months was 866.83K.

What is the market cap of ALIM currently?

The market value of ALIM currently stands at $301.29M with its latest stock price at $5.54 and 54.38M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	154
Beta	1.25
Sales or Revenue	$80.75M
5Y Sales Change%	-0.686%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic